Effects of ethinylestradiol–cyproterone acetate vs. pioglitazone–flutamide–metformin on plasma FGF21 levels in adolescent girls with androgen excess

Saved in:
Bibliographic Details
Published in:Diabetes & metabolism 2016-06, Vol.42 (3), p.196-199
Main Authors: Díaz, M, Gallego-Escuredo, J.M, de Zegher, F, Villarroya, F, Ibáñez, L
Format: Article
Language:English
Subjects:
Adolescent
Cyproterone Acetate - therapeutic use
Drug Combinations
Endocrinology & Metabolism
Ethinyl Estradiol - therapeutic use
Female
Fibroblast Growth Factors - blood
Flutamide - administration & dosage
Hirsutism - blood
Hirsutism - drug therapy
Hirsutism - etiology
Humans
Hyperandrogenism - blood
Hyperandrogenism - complications
Hyperandrogenism - drug therapy
Hyperinsulinism - blood
Hyperinsulinism - complications
Hyperinsulinism - drug therapy
Internal Medicine
Longitudinal Studies
Metformin - administration & dosage
Thiazolidinediones - administration & dosage
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c463t-88922f507a3f7231cde29c2f255eff8266322055f7044c73b35a4290fa68b1fd3
cites cdi_FETCH-LOGICAL-c463t-88922f507a3f7231cde29c2f255eff8266322055f7044c73b35a4290fa68b1fd3
container_end_page 199
container_issue 3
container_start_page 196
container_title Diabetes & metabolism
container_volume 42
creator Díaz, M
Gallego-Escuredo, J.M
de Zegher, F
Villarroya, F
Ibáñez, L
description
doi_str_mv 10.1016/j.diabet.2015.10.004
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1797254293</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1262363615001263</els_id><sourcerecordid>1797254293</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-88922f507a3f7231cde29c2f255eff8266322055f7044c73b35a4290fa68b1fd3</originalsourceid><addsrcrecordid>eNqFUj1vFDEQXSEQCYF_gJBLml38sfbuNkgoygWkSBRAbfns8cWH1z5s34Wj4j_Q8fP4JXh1gYKGyqOZ92Y8817TPCe4I5iIV9vOOLWG0lFMeE11GPcPmnMyDmNLhhE_rDEVtGWCibPmSc5bjAmd2Pi4OaOC94KNw3nz88pa0CWjaBGUWxeOHnJJyrjof33_oY-7FAukGAApDUUVQIfcoZ2LG--K-lYLFWb9vqjZmSWeodiYZhdQDGjnVZ4VWl2vKEEeDuAzqhVlYh2jIRS0canm7ly5RSqYFDcQEHzVkPPT5pFVPsOz-_ei-bS6-nj5tr15f_3u8s1Nq-sOpR3HiVLL8aCYHSgj2gCdNLWUc7B2pEIwSjHndsB9rwe2Zlz1dMJWiXFNrGEXzctT37rql33dXs6u_s17FSDusyTDNFBeKaxC-xNUp5hzAit3yc0qHSXBclFFbuVJFbmosmSrKpX24n7Cfj2D-Uv6I0MFvD4B6n3g4CDJrB0EDcalqo400f1vwr8NtHfBaeU_wxHyNu5TqDeURGYqsfywOGMxBuGLKQRjvwETNrph</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1797254293</pqid></control><display><type>article</type><title>Effects of ethinylestradiol–cyproterone acetate vs. pioglitazone–flutamide–metformin on plasma FGF21 levels in adolescent girls with androgen excess</title><source>ScienceDirect Journals</source><creator>Díaz, M ; Gallego-Escuredo, J.M ; de Zegher, F ; Villarroya, F ; Ibáñez, L</creator><creatorcontrib>Díaz, M ; Gallego-Escuredo, J.M ; de Zegher, F ; Villarroya, F ; Ibáñez, L</creatorcontrib><identifier>ISSN: 1262-3636</identifier><identifier>EISSN: 1878-1780</identifier><identifier>DOI: 10.1016/j.diabet.2015.10.004</identifier><identifier>PMID: 26546387</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Adolescent ; Cyproterone Acetate - therapeutic use ; Drug Combinations ; Endocrinology &amp; Metabolism ; Ethinyl Estradiol - therapeutic use ; Female ; Fibroblast Growth Factors - blood ; Flutamide - administration &amp; dosage ; Hirsutism - blood ; Hirsutism - drug therapy ; Hirsutism - etiology ; Humans ; Hyperandrogenism - blood ; Hyperandrogenism - complications ; Hyperandrogenism - drug therapy ; Hyperinsulinism - blood ; Hyperinsulinism - complications ; Hyperinsulinism - drug therapy ; Internal Medicine ; Longitudinal Studies ; Metformin - administration &amp; dosage ; Thiazolidinediones - administration &amp; dosage</subject><ispartof>Diabetes &amp; metabolism, 2016-06, Vol.42 (3), p.196-199</ispartof><rights>Elsevier Masson SAS</rights><rights>2015 Elsevier Masson SAS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-88922f507a3f7231cde29c2f255eff8266322055f7044c73b35a4290fa68b1fd3</citedby><cites>FETCH-LOGICAL-c463t-88922f507a3f7231cde29c2f255eff8266322055f7044c73b35a4290fa68b1fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26546387$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Díaz, M</creatorcontrib><creatorcontrib>Gallego-Escuredo, J.M</creatorcontrib><creatorcontrib>de Zegher, F</creatorcontrib><creatorcontrib>Villarroya, F</creatorcontrib><creatorcontrib>Ibáñez, L</creatorcontrib><title>Effects of ethinylestradiol–cyproterone acetate vs. pioglitazone–flutamide–metformin on plasma FGF21 levels in adolescent girls with androgen excess</title><title>Diabetes &amp; metabolism</title><addtitle>Diabetes Metab</addtitle><subject>Adolescent</subject><subject>Cyproterone Acetate - therapeutic use</subject><subject>Drug Combinations</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Ethinyl Estradiol - therapeutic use</subject><subject>Female</subject><subject>Fibroblast Growth Factors - blood</subject><subject>Flutamide - administration &amp; dosage</subject><subject>Hirsutism - blood</subject><subject>Hirsutism - drug therapy</subject><subject>Hirsutism - etiology</subject><subject>Humans</subject><subject>Hyperandrogenism - blood</subject><subject>Hyperandrogenism - complications</subject><subject>Hyperandrogenism - drug therapy</subject><subject>Hyperinsulinism - blood</subject><subject>Hyperinsulinism - complications</subject><subject>Hyperinsulinism - drug therapy</subject><subject>Internal Medicine</subject><subject>Longitudinal Studies</subject><subject>Metformin - administration &amp; dosage</subject><subject>Thiazolidinediones - administration &amp; dosage</subject><issn>1262-3636</issn><issn>1878-1780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqFUj1vFDEQXSEQCYF_gJBLml38sfbuNkgoygWkSBRAbfns8cWH1z5s34Wj4j_Q8fP4JXh1gYKGyqOZ92Y8817TPCe4I5iIV9vOOLWG0lFMeE11GPcPmnMyDmNLhhE_rDEVtGWCibPmSc5bjAmd2Pi4OaOC94KNw3nz88pa0CWjaBGUWxeOHnJJyrjof33_oY-7FAukGAApDUUVQIfcoZ2LG--K-lYLFWb9vqjZmSWeodiYZhdQDGjnVZ4VWl2vKEEeDuAzqhVlYh2jIRS0canm7ly5RSqYFDcQEHzVkPPT5pFVPsOz-_ei-bS6-nj5tr15f_3u8s1Nq-sOpR3HiVLL8aCYHSgj2gCdNLWUc7B2pEIwSjHndsB9rwe2Zlz1dMJWiXFNrGEXzctT37rql33dXs6u_s17FSDusyTDNFBeKaxC-xNUp5hzAit3yc0qHSXBclFFbuVJFbmosmSrKpX24n7Cfj2D-Uv6I0MFvD4B6n3g4CDJrB0EDcalqo400f1vwr8NtHfBaeU_wxHyNu5TqDeURGYqsfywOGMxBuGLKQRjvwETNrph</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Díaz, M</creator><creator>Gallego-Escuredo, J.M</creator><creator>de Zegher, F</creator><creator>Villarroya, F</creator><creator>Ibáñez, L</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160601</creationdate><title>Effects of ethinylestradiol–cyproterone acetate vs. pioglitazone–flutamide–metformin on plasma FGF21 levels in adolescent girls with androgen excess</title><author>Díaz, M ; Gallego-Escuredo, J.M ; de Zegher, F ; Villarroya, F ; Ibáñez, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-88922f507a3f7231cde29c2f255eff8266322055f7044c73b35a4290fa68b1fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Cyproterone Acetate - therapeutic use</topic><topic>Drug Combinations</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Ethinyl Estradiol - therapeutic use</topic><topic>Female</topic><topic>Fibroblast Growth Factors - blood</topic><topic>Flutamide - administration &amp; dosage</topic><topic>Hirsutism - blood</topic><topic>Hirsutism - drug therapy</topic><topic>Hirsutism - etiology</topic><topic>Humans</topic><topic>Hyperandrogenism - blood</topic><topic>Hyperandrogenism - complications</topic><topic>Hyperandrogenism - drug therapy</topic><topic>Hyperinsulinism - blood</topic><topic>Hyperinsulinism - complications</topic><topic>Hyperinsulinism - drug therapy</topic><topic>Internal Medicine</topic><topic>Longitudinal Studies</topic><topic>Metformin - administration &amp; dosage</topic><topic>Thiazolidinediones - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Díaz, M</creatorcontrib><creatorcontrib>Gallego-Escuredo, J.M</creatorcontrib><creatorcontrib>de Zegher, F</creatorcontrib><creatorcontrib>Villarroya, F</creatorcontrib><creatorcontrib>Ibáñez, L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes &amp; metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Díaz, M</au><au>Gallego-Escuredo, J.M</au><au>de Zegher, F</au><au>Villarroya, F</au><au>Ibáñez, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of ethinylestradiol–cyproterone acetate vs. pioglitazone–flutamide–metformin on plasma FGF21 levels in adolescent girls with androgen excess</atitle><jtitle>Diabetes &amp; metabolism</jtitle><addtitle>Diabetes Metab</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>42</volume><issue>3</issue><spage>196</spage><epage>199</epage><pages>196-199</pages><issn>1262-3636</issn><eissn>1878-1780</eissn><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>26546387</pmid><doi>10.1016/j.diabet.2015.10.004</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1262-3636
ispartof Diabetes & metabolism, 2016-06, Vol.42 (3), p.196-199
issn 1262-3636
1878-1780
language eng
recordid cdi_proquest_miscellaneous_1797254293
source ScienceDirect Journals
subjects Adolescent
Cyproterone Acetate - therapeutic use
Drug Combinations
Endocrinology & Metabolism
Ethinyl Estradiol - therapeutic use
Female
Fibroblast Growth Factors - blood
Flutamide - administration & dosage
Hirsutism - blood
Hirsutism - drug therapy
Hirsutism - etiology
Humans
Hyperandrogenism - blood
Hyperandrogenism - complications
Hyperandrogenism - drug therapy
Hyperinsulinism - blood
Hyperinsulinism - complications
Hyperinsulinism - drug therapy
Internal Medicine
Longitudinal Studies
Metformin - administration & dosage
Thiazolidinediones - administration & dosage
title Effects of ethinylestradiol–cyproterone acetate vs. pioglitazone–flutamide–metformin on plasma FGF21 levels in adolescent girls with androgen excess
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A40%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20ethinylestradiol%E2%80%93cyproterone%20acetate%20vs.%20pioglitazone%E2%80%93flutamide%E2%80%93metformin%20on%20plasma%20FGF21%20levels%20in%20adolescent%20girls%20with%20androgen%20excess&rft.jtitle=Diabetes%20&%20metabolism&rft.au=D%C3%ADaz,%20M&rft.date=2016-06-01&rft.volume=42&rft.issue=3&rft.spage=196&rft.epage=199&rft.pages=196-199&rft.issn=1262-3636&rft.eissn=1878-1780&rft_id=info:doi/10.1016/j.diabet.2015.10.004&rft_dat=%3Cproquest_cross%3E1797254293%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c463t-88922f507a3f7231cde29c2f255eff8266322055f7044c73b35a4290fa68b1fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1797254293&rft_id=info:pmid/26546387&rfr_iscdi=true